Lizhi Niu

机构：Fuda Cancer Hospital · ORCID：0000-0002-4221-1143

发表论文 35 篇 · 总被引 727 次 · h-index 14

代表论文

• Pembrolizumab plus allogeneic NK cells in advanced non–small cell lung cancer patients (2020 · Journal of Clinical Investigation · 被引 137)
• Clinical efficacy of percutaneous cryoablation combined with allogenic NK cell immunotherapy for advanced non-small cell lung cancer (2017 · Immunologic Research · 被引 69)
• Allogenic Natural Killer Cell Immunotherapy Combined with Irreversible Electroporation for Stage IV Hepatocellular Carcinoma: Survival Outcome (2018 · Cellular Physiology and Biochemistry · 被引 68)
• Percutaneous Cryoablation for Liver Cancer (2014 · Journal of Clinical and Translational Hepatology · 被引 56)
• Expert consensus on thermal ablation therapy of pulmonary subsolid nodules (2021 Edition) (2021 · Journal of Cancer Research and Therapeutics · 被引 54)
• Comparison of autogeneic and allogeneic natural killer cells immunotherapy on the clinical outcome of recurrent breast cancer (2017 · OncoTargets and Therapy · 被引 48)